Christopher Rentsch
@darthctr.bsky.social
Dual 🇺🇸🇬🇧 | Associate Prof LSHTM / Yale | Pharmacoepidemiology | Pharmacogenomics | Real-World Evidence | Views my own | 🏳️🌈🧑💻🎺
Reposted by Christopher Rentsch
🚨 Publication alert 🚨
Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform
Paper here: doi.org/10.1038/s438...
(1/3) @darthctr.bsky.social @annaschultze.bsky.social @bengoldacre.bsky.social @lshtm.bsky.social @bennettoxford.bsky.social
Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform
Paper here: doi.org/10.1038/s438...
(1/3) @darthctr.bsky.social @annaschultze.bsky.social @bengoldacre.bsky.social @lshtm.bsky.social @bennettoxford.bsky.social
Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform - Communications Medicine
Costello et al. assess the impact of ursodeoxycholic acid (UDCA) treatment on COVID-19-related outcomes among people with chronic primary biliary cirrhosis and primary sclerosing cholangitis. Using a ...
doi.org
November 20, 2024 at 12:03 PM
🚨 Publication alert 🚨
Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform
Paper here: doi.org/10.1038/s438...
(1/3) @darthctr.bsky.social @annaschultze.bsky.social @bengoldacre.bsky.social @lshtm.bsky.social @bennettoxford.bsky.social
Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform
Paper here: doi.org/10.1038/s438...
(1/3) @darthctr.bsky.social @annaschultze.bsky.social @bengoldacre.bsky.social @lshtm.bsky.social @bennettoxford.bsky.social